127 related articles for article (PubMed ID: 33732838)
1. A mutilating, persistent lip ulcer as a presenting sign of oral mycosis fungoides with large cell transformation.
Robinson CL; Sethupathi SK; Fairley JA; Link BK; Liu V
JAAD Case Rep; 2021 Apr; 10():14-17. PubMed ID: 33732838
[No Abstract] [Full Text] [Related]
2. Oral mycosis fungoides with CD30
Goggins CA; Gocke MT; Jang S; DeSimone JA
JAAD Case Rep; 2019 Feb; 5(2):180-183. PubMed ID: 30733988
[No Abstract] [Full Text] [Related]
3. Utility of CD30, Ki-67, and p53 in assisting with the diagnosis of mycosis fungoides with large cell transformation.
Raghavan SS; Hong EK; Kim YH; Kim J
J Cutan Pathol; 2019 Jan; 46(1):33-43. PubMed ID: 30328119
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
5. Mycosis fungoides with large cell transformation: clinicopathological features and prognostic factors.
Pulitzer M; Myskowski PL; Horwitz SM; Querfeld C; Connolly B; Li J; Murali R
Pathology; 2014 Dec; 46(7):610-6. PubMed ID: 25393251
[TBL] [Abstract][Full Text] [Related]
6. Large Cell Transformation of Oral Mycosis Fungoides.
Sultan AS; Mostoufi B; Papadimitriou JC; Koka R; Basile J; Younis RH
Head Neck Pathol; 2018 Jun; 12(2):247-251. PubMed ID: 28741231
[TBL] [Abstract][Full Text] [Related]
7. A CD30(-) Transformed Mycosis Fungoides Case Responding Very Well to Systemic Bexarotene and Methotrexate.
Zindanci I; Kavala M; Turkoğlu Z; Can B; Ozturk E; Zemheri E; Akbulak O; Mansuroglu C; Topaloğlu Demir F
Int J Low Extrem Wounds; 2014 Jun; 13(2):127-129. PubMed ID: 24872469
[TBL] [Abstract][Full Text] [Related]
8. Targeted Deep Sequencing of Mycosis Fungoides Reveals Intracellular Signaling Pathways Associated with Aggressiveness and Large Cell Transformation.
Wobser M; Roth S; Appenzeller S; Houben R; Schrama D; Goebeler M; Geissinger E; Rosenwald A; Maurus K
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771672
[TBL] [Abstract][Full Text] [Related]
9. Recognizing large-cell transformation of mycosis fungoides.
Herrmann JL; Hughey LC
J Am Acad Dermatol; 2012 Oct; 67(4):665-72. PubMed ID: 22261416
[TBL] [Abstract][Full Text] [Related]
10. Folliculotropic mycosis fungoides with large-cell transformation presenting as dissecting cellulitis of the scalp.
Gilliam AC; Lessin SR; Wilson DM; Salhany KE
J Cutan Pathol; 1997 Mar; 24(3):169-75. PubMed ID: 9085153
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system involvement in patients with mycosis fungoides and cutaneous large-cell transformation.
Vu BA; Duvic M
J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S16-22. PubMed ID: 18625371
[TBL] [Abstract][Full Text] [Related]
12. Large-cell transformation of mycosis fungoides-differential diagnosis with implications for clinical management: a consensus statement of the US Cutaneous Lymphoma Consortium.
Kadin ME; Hughey LC; Wood GS
J Am Acad Dermatol; 2014 Feb; 70(2):374-6. PubMed ID: 24438952
[No Abstract] [Full Text] [Related]
13. Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides.
Wieser I; Wang C; Alberti-Violetti S; Lyons G; Tran C; Talpur R; Duvic M
Arch Dermatol Res; 2017 Aug; 309(6):453-459. PubMed ID: 28516243
[TBL] [Abstract][Full Text] [Related]
14. Retrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis Fungoides.
Talpur R; Sui D; Gangar P; Dabaja BS; Duvic M
Clin Lymphoma Myeloma Leuk; 2016 Jan; 16(1):49-56. PubMed ID: 26702474
[TBL] [Abstract][Full Text] [Related]
15. A case-control study of clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides.
Li JY; Pulitzer MP; Myskowski PL; Dusza SW; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2013 Sep; 69(3):366-74. PubMed ID: 23685027
[TBL] [Abstract][Full Text] [Related]
16. Transformation of mycosis fungoides: T-cell receptor beta gene analysis demonstrates a common clonal origin for plaque-type mycosis fungoides and CD30+ large-cell lymphoma.
Wood GS; Bahler DW; Hoppe RT; Warnke RA; Sklar JL; Levy R
J Invest Dermatol; 1993 Sep; 101(3):296-300. PubMed ID: 8396607
[TBL] [Abstract][Full Text] [Related]
17. Mycosis fungoides in Taiwan shows a relatively high frequency of large cell transformation and CD56 expression.
Wang RC; Sakata S; Chen BJ; Chang ST; Hsieh PP; Yang CS; Baba S; Takeuchi K; Chuang SS
Pathology; 2018 Dec; 50(7):718-724. PubMed ID: 30348505
[TBL] [Abstract][Full Text] [Related]
18. Transformation in mycosis fungoides: the role of methotrexate.
Abd-el-Baki J; Demierre MF; Li N; Foss FM
J Cutan Med Surg; 2002; 6(2):109-16. PubMed ID: 11992182
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases.
Benner MF; Jansen PM; Vermeer MH; Willemze R
Blood; 2012 Feb; 119(7):1643-9. PubMed ID: 22160616
[TBL] [Abstract][Full Text] [Related]
20. Juvenile mycosis fungoides with large-cell transformation: Successful treatment with psoralen with ultraviolet A light, interferon-alfa, and localized radiation.
Chan WH; Lewis DJ; Hinojosa T; Curry JL; Duvic M
Pediatr Dermatol; 2018 Jan; 35(1):e13-e16. PubMed ID: 29159918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
